Electrophysiological effects of intravitreal Avastin (bevacizumab) in the treatment of exudative age-related macular degeneration

British Journal of Ophthalmology

Volumn 92, Issue 9, 2008, Pages 1248-1252

  Karanjia, R ^a   Eng, K T ^a   Gale, J ^a   Sharma, S ^a   Ten Hove, M W ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ELECTRIC ACTIVITY; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; PATHOLOGY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 51149118037     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2008.138800     Document Type: Article

References (19)

1. Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina 2005;25:111-18.
2. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611.
3. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42.
4. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355:1432-44.
5. Boyer DS, Antoszyk AN, Awh CC, et al. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:246-52.
6. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
7. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
8. Michels S, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 2005;112:1035-47.
9. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006;26:352- 4.
10. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastinl for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-72.
11. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-9.
12. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-5.
13. Maturi RK, Bleau LA, Wilson DL Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment. Retina 2006;26:270- 4.
14. Palmowski AM, Allgayer R, Heinemann-Vemaleken B, et al. Influence of photodynamic therapy in choroidal neovascularization on focal retinal function assessed with the multifocal electroretinogram and perimetry. Ophthalmology 2002;109:1788-92.
15. Schneck ME, Bearse MA Jr, Han Y, et al. Comparison of mfERG waveform components and implicit time measurement techniques for detecting functional change in early diabetic eye disease. Doc Ophthalmol 2004;108:223-30.
16. Rohrschneider K. Determination of the location of the fovea on the fundus. Invest Ophthalmol Vis Sci 2004;45:3257-8.
17. Inan UU, Avci B, Kusbeci T, et al. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes. Invest Ophthalmol Vis Sci 2007;48:1773-81.
18. Hood DC, Holopigian K, Greenstein V, et al. Assessment of local retinal function in patients with retinitis pigmentosa using the multi-focal ERG technique. Vision Res 1998;38:163-79.
19. Hood DC, Li J. A technique for measuring individual multifocal ERG records. Opt Soc Am Trends Opt Photon 1997;11:33-41.